NCT06429800 2025-04-24A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants With Systemic Lupus ErythematosusAtara BiotherapeuticsPhase 1 Withdrawn
NCT06238531 2025-03-13A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or LupusNational Institutes of Health Clinical Center (CC)Phase 1 Withdrawn